In this episode of Talks at GS, Dr. Michael Mina of the Harvard T.H. Chan School of Public Health discusses the evolving understanding of COVID-19 biology and epidemiology and approaches to “flatten the curve” in the context of diagnostics, potential therapeutics and vaccines.

This conversation was recorded as a phone call between Dr. Mina and Salveen Richter and Terence Flynn of Goldman Sachs Research on March 17, 2020.